Erin Hertlein, PhD

Erin Hertlein


College of Medicine


Internal Medicine

Academic Title

Res Asst Professor

Research Program

Leukemia Research

Research Interest

Leukemia, Lymphocytic, Chronic, B-Cell, Cancer, Leukemia, Lymphoma, Lymphoma, Mantle-Cell, Leukemia, B-Cell, Leukemia, Hairy Cell

Dr. Hertlein has been extensively involved in NF-?B and other cancer relevant cell signaling pathways throughout my career. Her work has focused on the mechanism of several therapeutic agents in chronic lymphocytic leukemia (CLL). She is currently pursuing novel therapies which target Hsp90, EZH2, IDH proteins and other epigenetic pathways in lymphoid and myeloid diseases including diffuse large B cell lymphoma (DLBCL) and acute myeloid leukemia (AML). Dr. Hertlein's focus includes studying the therapeutic mechanisms of these agents, including combination therapy and clinical application. She is also investigating how these epigenetic modifiers intersect with non-coding RNAs (miRs, lncRNAs) to mediate transcriptional regulation.

Education and Background

Office Location

481-C OSUCCC Building

410 W 12th Ave, Columbus, OH 43210



Back to Researcher Search

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Search for Clinical Trials

Find a Scientific Publication